Europe High-Flow Nasal Cannula Market to 2027 - Regional Analysis and Forecasts by Component (Air Oxygen Blender, Nasal Cannula, Heated Inspiratory Circuit, and Active Humidifier); Application (Bronchiectasis, Acute Respiratory Failure, Acute Heart Failure, and Chronic Obstructive Pulmonary Disease); End User (Ambulatory Care Centers, Hospitals and Long-Term Care Centers) and Country
Publication Month: Jan 2020
Report Code: TIPRE00007980 No. of Pages: 139 Category: Medical Device Status: Published
The Europe high flow nasal cannula market is expected to reach US$ 3,298.04 Mn in 2027 from US$ 1,327.65 Mn in 2018. The market is projected to grow with a CAGR of 10.8% from 2019-2027.
The key factors that are driving the growth of the market are growing asthma cases in adults and children, and increasing lung cancer conferences across Europe. However, the factors restraining the market growth are side effects associated with high flow nasal cannula.
In Europe, lung cancer is the biggest cancer killer, accounting for 20.8% of all cancer deaths. Nevertheless, it has been observed that recent progress in lung cancer research now offers new hopes for the future. In the UK, during the year 2014 - 2016, there were around 47,200 new lung cancer cases every year. It is the 3rd most common cancer, accounting for 13% of all new cancer cases. In the UK, lung cancer is the 2nd most common cancer in females, with approximately 22,300 new cases in 2016. However, In males, it was the 2nd most common cancer during the year 2016, with 25,000 new cases. Incidence rates for lung cancer are highest in people aged 85 to 89. Over the last decade, lung cancer incidence rates have been increased by less than a twentieth (2%) in the UK. Other chronic diseases includes COPD, asthma, and etc. Older people with asthma often need high doses of medication, in spite of mild asthma attacks. Therefore, they are more likely to suffer from respiratory failure much faster as compared to the younger population. Also, COPD can appear at any age. However, it is more prevalent in the older population and can be fatal. The aging population is growing exponentially worldwide.
UK is anticipated to lead the adoptions of high flow nasal cannula across the Europe region through the forecast period. Respiratory diseases in the UK are a significant burden on the economy of the country and cost a substantial amount of their expenditure. The annual economic burden of respiratory conditions such as asthma and COPD on the NHS in the UK is estimated to be around US$ 3.0 billion (i.e., £3 billion) and nearly US$ 2.47 billion (i.e., £1.9 billion) respectively. Moreover, the overall expenditure of all the lung conditions, including lung cancer, directly costs the NHS in the UK approximately US$ 14.30 billion (i.e., £11billion) annually.
UK High Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn) Get more information on this report : 
- Air Oxygen Blender
- Nasal Cannula
- Heated Inspiratory Circuit
- Active Humidifier
- Bronchiectasis
- Acute Respiratory Failure
- Acute Heart Failure
- Chronic Obstructive Pulmonary Disease (COPD)
- Hospitals
- Ambulatory Care Centers
- Long-Term Care Centers
Europe High Flow Nasal Cannula market
By Country
- Europe
- UK
- Germany
- France
- Italy
- Spain
Companies Mentioned
- Great Group Medical Co., Ltd.
- Salter Labs
- Fisher And Paykel Healthcare Limited
- TNI Medical Ag
- Mek-Ics Co., Ltd.
- Flexicare Medical Limited
- Vapotherm
- Teleflex Incorporated
- Resmed
- Hamilton Medical Inc,
1. Introduction
1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance
2. Europe High-Flow Nasal Cannula Market – Key Takeaways
3. Europe High-Flow Nasal Cannula Market– Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Europe High-Flow Nasal Cannula Market – By Component
3.2.2 Europe High-Flow Nasal Cannula Market – By Application
3.2.3 Europe High-Flow Nasal Cannula Market – By End User
3.2.4 Europe High-Flow Nasal Cannula Market – By Europe Countries
3.3 PEST Analysis
4. Europe High-Flow Nasal Cannula Market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Lung Cancer Conferences Across Europe
4.1.2 Growing Asthma Cases in Adults and Children
4.2 Key Market Restraints
4.2.1 Side Effects Associated with High Flow Nasal Cannula
4.3 Key Market Opportunity
4.3.1 Growing Geriatric Population
4.4 Future Trend
4.4.1 Increasing Acceptance Of Home Oxygen Therapy
4.5 Impact Analysis
5. High-Flow Nasal Cannula Market – Europe Analysis
5.1 Europe High-Flow Nasal Cannula Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Performance Of Key Players
- Fisher & Paykel Healthcare Limited
- ResMed
6. Europe High-Flow Nasal Cannula Market Analysis – By Component
6.1 Overview
6.2 Component Market Revenue And Forecasts Analysis (US$ Mn)
6.3 Air Oxygen Blender
6.3.1 Overview
6.3.2 Europe Air Oxygen Blender Market Revenue And Forecast To 2027 (US$ Mn)
6.4 Nasal Cannula
6.4.1 Overview
6.4.2 Europe Nasal Cannula Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Heated Inspiratory Circuit
6.5.1 Overview
6.5.2 Europe Heated Inspiratory Circuit Market Revenue and Forecast to 2027 (US$ Mn)
6.6 Active Humidifier
6.6.1 Overview
6.6.2 Europe Active Humidifier Market Revenue and Forecast to 2027 (US$ Mn)
7. Europe High-Flow Nasal Cannula Market Analysis – By Application
7.1 Overview
7.2 Europe High-Flow Nasal Cannula Market, By Application 2018 & 2027 (%)
7.3 Bronchiectasis
7.3.1 Overview
7.3.2 Europe Bronchiectasis Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Acute Respiratory Failure
7.4.1 Overview
7.4.2 Europe Acute Respiratory Failure Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Acute Heart Failure
7.5.1 Overview
7.5.2 Europe Acute Heart Failure Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Chronic Obstructive Pulmonary Disease
7.6.1 Overview
7.6.2 Europe Chronic Obstructive Pulmonary Disease Market Revenue and Forecast to 2027 (US$ Mn)
8. Europe High-Flow Nasal Cannula Market Analysis – By End User
8.1 Overview
8.2 Europe High-Flow Nasal Cannula Market, By Applicaton 2018 & 2027 (%)
8.3 Ambulatory Surgical Centers
8.3.1 Overview
8.3.2 Europe Ambulatory Surgical Centers Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Hospitals
8.4.1 Overview
8.4.2 Europe Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Long-Term Care Centers
8.5.1 Overview
8.5.2 Europe Long-Term Care Centers Market Revenue and Forecast to 2027 (US$ Mn)
9. Europe High-Flow Nasal Cannula Market Revenue And Forecasts To 2027
9.1 Europe High-Flow Nasal Cannula Market
9.1.1 Overview
9.1.2 Europe High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.3 Europe High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.4 Europe High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.5 Europe High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.6 Europe High-Flow Nasal Cannula Market Revenue and Forecasts to 2027, By Country (%)
9.1.7 Germany
9.1.7.1 Germany High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 Germany High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.7.3 Germany High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.7.4 Germany High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.8 UK
9.1.8.1 UK High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.2 UK High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.8.3 UK High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.8.4 UK High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.9 France
9.1.9.1 France High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.2 France High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.9.3 France High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.9.4 France High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.10 Spain
9.1.10.1 Spain High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.10.2 Spain High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.10.3 Spain High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.10.4 Spain High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.11 Italy
9.1.11.1 Italy High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.11.2 Italy High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.11.3 Italy High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.11.4 Italy High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10. High-Flow Nasal Cannula Market –Industry Landscape
10.1 Overview
10.1.1 Recent Developments by Players in the High-Flow Nasal Cannula Market
11. High-Flow Nasal Cannula Market–Key Company Profiles
11.1 Fisher & Paykel Healthcare Limited
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 ResMed.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Teleflex Incorporated
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Information
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Hamilton Company
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Great Group Medical Co., Ltd.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Information
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Salter Labs (SunMed, LLC)
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 TNI medical AG.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Flexicare (Group) Limited
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Vapotherm
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 MEK-ICS CO., LTD.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Solution Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary Of Terms
12.3 Methodology
12.4 Coverage
12.5 Secondary Research
12.6 Primary Research
LIST OF TABLES
Table 1. Total Number Of Persons Aged 60 Years Or Above By Region, 2017 & 2050
Table 2. Europe High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By Component (US$ Mn)
Table 3. Europe High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 4. Europe High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 5. Germany High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By Component (US$ Mn)
Table 6. Germany High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 7. Germany High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 8. UK High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By Component (US$ Mn)
Table 9. UK High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 10. UK High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 11. France High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By Component (US$ Mn)
Table 12. France High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 13. France High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 14. Spain High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By Component (US$ Mn)
Table 15. Spain High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 16. Spain High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 17. Italy High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By Component (US$ Mn)
Table 18. Italy High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 19. Italy High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 20. Recent Developments In The High-Flow Nasal Cannula Market
Table 21. Glossary Of Terms, High-Flow Nasal Cannula Market
LIST OF FIGURES
Figure 1. UK High-Flow Nasal Cannula Market, Revenue (US$ Mn), By 2018 & 2027
Figure 2. Europe High-Flow Nasal Cannula Market By Component, Market Share (%), 2018
Figure 3. Europe High-Flow Nasal Cannula Market By Application, Market Share (%), 2018
Figure 4. Europe High-Flow Nasal Cannula Market By End User, Market Share (%), 2018
Figure 5. High-Flow Nasal Cannula Market Segmentation
Figure 6. High-Flow Nasal Cannula Market In Europe: Pest Analysis
Figure 7. Europe High- Flow Nasal Cannula Market Impact Analysis Of Driver And Restraints
Figure 8. Europe High-Flow Nasal Cannula Market – Revenue Forecasts And Analysis –2018- 2027
Figure 9. Component Market Analysis And Forecasts 2018 And 2027 (%)
Figure 10. Europe Air Oxygen Blender Market Revenue And Forecast To 2027 (US$ Mn)
Figure 11. Europe Nasal Cannula Market Revenue And Forecast To 2027 (US$ Mn)
Figure 12. Europe Heated Inspiratory Circuit Market Revenue And Forecast To 2027 (US$ Mn)
Figure 13. Europe Active Humidifier Market Revenue And Forecast To 2027 (US$ Mn)
Figure 14. Europe High-Flow Nasal Cannula Market Breakdown, By Application 2018 & 2027 (%)
Figure 15. Europe Bronchiectasis Market Revenue And Forecast To 2027 (US$ Mn)
Figure 16. Europe Acute Respiratory Failure Market Revenue And Forecast To 2027 (US$ Mn)
Figure 17. Europe Acute Heart Failure Market Revenue And Forecast To 2027 (US$ Mn)
Figure 18. Europe Chronic Obstructive Pulmonary Disease Market Revenue And Forecast To 2027 (US$ Mn)
Figure 19. Europe High-Flow Nasal Cannula Market Breakdown, By End User 2018 & 2027 (%)
Figure 20. Europe Ambulatory Surgical Centers Market Revenue And Forecast To 2027 (US$ Mn)
Figure 21. Europe Hospitals Market Revenue And Forecast To 2027 (US$ Mn)
Figure 22. Europe Long-Term Care Centers Market Revenue And Forecast To 2027 (US$ Mn)
Figure 23. Europe High-Flow Nasal Cannula Market Revenue, By Country, 2018 (US$ Mn)
Figure 24. Europe High-Flow Nasal Cannula Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 25. Europe High-Flow Nasal Cannula Market Revenue And Forecasts To 2027, By Country (%)
Figure 26. Germany High-Flow Nasal Cannula Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 27. UK High-Flow Nasal Cannula Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 28. France High-Flow Nasal Cannula Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 29. Spain High-Flow Nasal Cannula Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 30. Italy High-Flow Nasal Cannula Market Revenue And Forecasts To 2027 (US$ Mn)
The List of Companies in Europe High-Flow Nasal Cannula Market
- Great Group Medical Co., Ltd.
- Salter Labs
- Fisher And Paykel Healthcare Limited
- TNI Medical Ag
- Mek-Ics Co., Ltd.
- Flexicare Medical Limited
- Vapotherm
- Teleflex Incorporated
- Resmed
- Hamilton Medical Inc,
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Drug delivery system market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Europe high-flow nasal cannula market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.